Some email communications may be filtered to your Spam or Junk folder, even if you have subscribed to them. Please mark aaciupdate@aaci-cancer.ccsend.com as a Safe Sender to ensure that AACI emails are delivered to your inbox.
| |
|
Following an extensive national search, Diane M. Simeone, MD, has been appointed director of UC San Diego Moores Cancer Center, effective April 1. Dr. Simeone currently serves as the Laura and Isaac Perlmutter Professor of Surgery, director of the Pancreatic Cancer Center, and the associate director of translational research at Perlmutter Cancer Center at NYU Langone. Read More
| |
|
Oncologist and researcher, Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), died January 21. Dr. Mitchell was slated to present a keynote at the 2024 AACI Leadership Diversity and Development Workshop. She shared her expertise at meetings of AACI's Clinical Research Innovation and Physician Clinical Leadership Initiative and as a member of the Leadership Diversity and Development Initiative Steering Committee. At the time of her death, Dr. Mitchell was the enterprise vice president for cancer disparities at Sidney Kimmel Cancer Center at Jefferson Health. Read More
| |
|
Registration is now open for AACI's joint Hill Day with the American Association for Cancer Research (AACR), which will take place in Washington, DC, on Thursday, May 16. Your participation in Hill Day is critical to sharing our message with our legislators in Washington: that stable, predictable funds are needed to advance cancer research and care at our nation’s cancer centers. Read More
| |
|
Abstract submissions are now being accepted for the 16th Annual AACI CRI Meeting, June 24-26, at the Loews Chicago O'Hare Hotel in Rosemont, IL. This year’s meeting theme will focus on compassion and collaboration through clinical trials. Please visit the 2024 Call for Abstracts page for important dates, templates, and more information. Read More
| |
|
Ted A. James, MD, MHCM, FACS, will present the closing keynote, "Inclusive Team Building: Strategies for Cancer Center Leadership Excellence," at 1:15 pm central time on Wednesday, March 13, during the 2024 AACI Leadership Diversity and Development Workshop in Rosemont, IL. Dr. James is a surgical oncologist and cancer center medical director dedicated to transforming health care by promoting patient-centered care and fostering positive workplace culture. Read More
| |
|
AACI members are invited to submit nominations for the 2024 Champion for Cures and Cancer Health Equity awards. The submission deadline for both awards is Monday, April 1. The awards will be presented during the 2024 AACI/CCAF Annual Meeting, October 20-22, at the Loews Chicago Hotel.
Pictured: 2023 AACI Cancer Health Equity Award recipient Dr. Amelie Ramirez and AACI Executive Director Jennifer W. Pegher
Read More
| |
|
The Society of Women in Urologic Oncology (WUO) has named Amy Luckenbaugh, MD, to chair its executive board until November 2025. She is the inaugural chair of the WUO, whose core objective is to advance the recruitment, retention, and promotion of women in urologic oncology with the goal of fostering diversity, equity, and inclusion within the Society of Urologic Oncology. Read More
| |
|
Rebecca Shulman, MD, was recently recognized with the American Society for Radiation Oncology-Breast Cancer Research Foundation Emerging Investigator Award to Build a Diverse Scientific Workforce. Her project, "Combination Therapy with Radiotherapy, Immune Checkpoint Blockade, and Curaxin Enhances Tumor Regression in Metastatic Triple-Negative Breast Cancer," is a collaborative undertaking with Siddharth Balachandran, PhD. Read More
| |
|
Grant Challen, PhD, a Washington University researcher at Siteman Cancer Center, has received a Leukemia & Lymphoma Society Career Development Program Scholar Achievement Award, which will provide funding for two to five years. Read More
| |
|
Miriam Merad, MD, PhD, was elected as a Fellow of the American Association for Cancer Research (AACR) Academy, for her contributions in elucidating the roles of myeloid cells in inflammation and tumorigenesis and paving the way for the advancement of targeted therapies focusing on myeloid cells in both cancer and inflammatory diseases. Read More
| |
|
The American Urological Association has announced that Sam S. Chang, MD, MBA, is one of its 2024 award recipients who will be recognized at the organization’s annual meeting in May in San Antonio. He has been chosen for the Hugh Hampton Young Award, which is presented annually to an individual for outstanding contributions to the study of genitourinary tract diseases. Read More
| |
|
Duke Cancer Institute physician scientist Brent Hanks, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI), one of the nation's oldest medical honor societies. The ASCI supports the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve health. Read More
| |
|
Huntsman Cancer Institute and the University of Utah have named Umang Swami, MD, MS, and Matthew Covington, MD, as members of The Society of Huntsman Translational Scholars. This institutional initiative recognizes excellence in translational science and allows researchers to apply fundamental scientific findings to address clinical challenges in patient care. Read More
| |
|
Lori J. Pierce, MD, was one of 30 cancer scientists elected to the American Association for Cancer Research (AACR) class of Fellows of the AACR Academy. Dr. Pierce is professor of radiation oncology at Michigan Medicine and vice provost for academic and faculty affairs at the University of Michigan. Read More
| |
|
In recognition of his dedication toward advancements in lung cancer care as well as his contributions as a valued mentor, Roswell Park Comprehensive Cancer Center chair of thoracic surgery, Sai Yendamuri, MD, MBA, FACS, has recently been honored with prestigious leadership roles, awards, and grant funding from both local and national organizations. Read More
| |
|
The American Association for Women in Radiology (AAWR) awarded the 2023 AAWR Marie Sklodowska-Curie Award to Winship Cancer Institute researcher Reshma Jagsi, MD, DPhil, Lawrence W. Davis professor and chair of radiation oncology at the Emory University School of Medicine. Read More
| |
|
Huntsman Cancer Institute at the University of Utah rang in the new year with new leadership roles for Theresa Werner, MD, and Neeraj Agarwal, MD, FASCO. Dr. Werner is the new deputy director of Huntsman Cancer Institute and Dr. Agarwal is the new senior director for clinical research. Read More
| |
|
David Linehan, MD, is the new CEO of the University Rochester Medical Center (URMC), dean of the School of Medicine and Dentistry, and senior vice president for health sciences. Prior to this appointment, the surgical oncologist, internationally renowned for his clinical innovation and research into new treatments for pancreatic cancer, guided URMC’s Department of Surgery through a period of tremendous growth. Read More
| |
|
Jennifer Gillette, PhD, has been named the UNM Comprehensive Cancer Center associate director for training and education. Dr. Gillette is a professor and senior director for research for the UNM Department of Pathology. Angela Wandinger-Ness, PhD, formerly held this role through the most recent Cancer Center Support Grant competitive renewal. Read More
| |
|
Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN, MSA, as the vice president of the Karmanos Cancer Network, part of McLaren Health Care. The network has 15 locations anchored by the Karmanos freestanding cancer hospital headquartered in Detroit. Read More
| |
|
Shikhar Mehrotra, PhD, will take on the role of co-leader of the cancer biology and immunology research program at MUSC Hollings Cancer Center alongside Philip Howe, PhD. As co-leader, Dr. Mehrotra anticipates seeing more collaborative projects that take a holistic view of the mechanisms of cancer growth. Read More
| |
|
Following a national search, Roswell Park Comprehensive Cancer Center has selected George T. "Buddy" Hickman as its new chief digital & information officer. Hickman succeeds Tom Furlani, PhD, who retires this month. Hickman comes to Roswell Park with 30 years of experience in health care senior leadership. He was most recently with First Health Advisory, where he served as chief strategy officer. Read More
| |
|
UCLA Health has appointed leading breast surgical oncologist Mediget Teshome, MD, as the new chief of breast surgery and director of breast health. Before joining UCLA, Dr. Teshome was an associate professor at The University of Texas MD Anderson Cancer Center in the department of breast surgical oncology. Read More
| |
AACI and the Catchment Area Research Data Science (CARDS) listserv community announce a series of webinars dedicated to discussions around cancer center data collection, analysis, and utilization. The CARDS listserv and webinars are aimed at individuals at AACI cancer centers working in community outreach, biostatistics, and cancer informatics. The first CARDS webinar, "Unveiling Insights: Using Data to Guide Catchment Area Strategy," will be held Wednesday, February 21 at 1:00 pm eastern time. Read More | |
The American Cancer Society Leadership in Oncology Navigation (ACS LION) is a standardized training and credentialing program that helps patient navigators deliver essential nonclinical support to individuals, caregivers, and families facing cancer. The goal of the program is to help build a standardized professional knowledge base and positively impact oncology patients by expanding access to high-quality navigation programs and services. Standardized training will also help reduce barriers and health disparities among various patient groups. Read More | |
A new call-to-action published in the journal Cancer details practical steps for the oncology research and clinical care communities to expand access to clinical trials and enable patients to participate closer to their homes. The paper, authored by members of an American Society of Clinical Oncology (ASCO) Task Force, illuminates the importance of enabling patients to receive trial related testing and care near their homes, rather than requiring patients to travel to major research institutions hours from where they live. Read More | |
Karmanos Cancer Institute has announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma. The TheraBionic P1 emits low levels of radio-frequency electromagnetic fields that block the growth of tumor cells without affecting healthy tissue. Read More | |
The UNM Comprehensive Cancer Center completed the first allogeneic stem cell transplant in the state. The team also recently completed a haploidentical transplant. Such transplants make treatment possible for many New Mexican patients, who may not find matched donors in the registries of unrelated donors. Matthew Fero, MD, leads the stem cell transplantation team. Read More | |
The OSUCCC – James, in collaboration with Nationwide Children’s Hospital, recently celebrated the opening of a $100 million, 55,000-square-foot Proton Therapy Center, the first treatment facility in central Ohio to offer this highly targeted radiation therapy for treating complex tumors. Read More | |
AACI invites you to promote your cancer center or business by purchasing an ad in the AACI Update. Your newsletter ad may highlight a conference or a new initiative. Supporters may include links to their website and any upcoming events. Ads can be purchased monthly or in one of several packages. Read More | | |
|
|
PO Box 7317
Pittsburgh, PA 15213
412-647-6111
| | | | | |